Helping to Bring Improved and Novel Therapies to the Right Patient Population Faster
Oncolines Hosts Webinar: Biomarkers for Patient Stratification & Target Engagement
Despite significant advances made in the treatment of cancer through the past decades, many new therapeutic entities fail in [...]
New Oncolines publication in Cancers
IL4I1 in ascites as a marker in high-grade serous ovarian cancer The emergence of immunotherapy has revolutionized [...]
Oncolines Team Joins Symeres
Symeres acquires Oncolines, further strengthening its drug discovery and biology capabilities Nijmegen, the Netherlands: Symeres, a [...]